Is fluticasone (inhalation corticosteroid) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluticasone Use During Pregnancy

Fluticasone (both inhaled and intranasal formulations) is safe to use during pregnancy and should be continued at the lowest effective dose to maintain disease control. 1

Safety Profile and Evidence

Inhaled corticosteroids, including fluticasone, have not been associated with increased risk of major congenital malformations, intrauterine growth restriction, preterm delivery, or low birth weight at usual therapeutic doses. 1

Key Safety Data:

  • Fluticasone is classified as FDA Pregnancy Category C, but this reflects lack of controlled human studies rather than evidence of harm 2
  • The European Respiratory Society/Thoracic Society of Australia and New Zealand designates fluticasone as "compatible" for use during pregnancy 1
  • A large UK population-based cohort study of 5,362 pregnancies found no increased risk of major congenital malformations with first-trimester fluticasone exposure compared to other inhaled corticosteroids (adjusted OR 1.2,95% CI 0.7-2.0) 3
  • A meta-analysis confirmed that intranasal corticosteroids during pregnancy do not increase risks of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension 1

Clinical Recommendations

For Asthma Management:

  • Continue fluticasone if the patient was well-controlled on it pre-pregnancy 1
  • Use the lowest dose necessary to maintain asthma control 1
  • While budesonide has more extensive pregnancy safety data and is technically preferred when initiating therapy, switching from fluticasone to budesonide is unnecessary if asthma is already well-controlled 1

For Rhinitis/Rhinosinusitis:

  • All modern intranasal corticosteroids including fluticasone propionate and fluticasone furoate are safe at recommended doses 1
  • Intranasal fluticasone has reassuring safety data with accumulated evidence supporting its use 1
  • If initiating intranasal corticosteroid therapy during pregnancy, budesonide (Pregnancy Category B) may be marginally preferred due to more extensive human data, but continuing pre-pregnancy fluticasone is entirely reasonable 1

Important Caveats and Considerations

Dose-Related Concerns:

  • One study suggested that beclomethasone doses >1000 µg/day may be associated with a small increased risk of congenital malformations 1
  • This threshold concern likely applies to all inhaled corticosteroids, emphasizing the importance of using the minimum effective dose 4
  • The risks of poorly controlled asthma (maternal hypoxia, preeclampsia, preterm delivery) far outweigh theoretical medication risks 4

Formulation-Specific Notes:

  • Intranasal fluticasone propionate showed no efficacy benefit over placebo in one small study of pregnancy rhinitis, though safety was confirmed 5
  • Despite this single negative efficacy study, intranasal fluticasone remains a reasonable option given its established safety profile 6
  • Systemic absorption from intranasal administration is substantially lower than from inhaled formulations 7

FDA Label Information:

  • Animal studies showed fetal toxicity at doses equivalent to or exceeding maximum human doses, including cleft palate and growth retardation 2
  • However, these animal findings have not translated to human risk in observational studies 3, 6
  • The FDA label states fluticasone "should be used during pregnancy only if the potential benefit justifies the potential risk," which is standard Category C language 2

Practical Management Algorithm

  1. If patient is already on fluticasone pre-pregnancy with good control:

    • Continue current regimen 1
    • Optimize dose to lowest effective level 1
    • Monitor asthma/rhinitis control throughout pregnancy 1
  2. If initiating therapy during pregnancy:

    • Budesonide is marginally preferred for inhaled corticosteroids due to Category B designation 1
    • For intranasal use, budesonide, fluticasone, or mometasone are all acceptable first-line options 1
  3. Avoid:

    • Unnecessary medication switches in well-controlled patients 1
    • Undertreating respiratory disease due to pregnancy concerns 4
    • Off-label high-dose budesonide irrigations or nasal drops 1

Breastfeeding Compatibility

Fluticasone is compatible with breastfeeding, as systemic absorption from inhaled or intranasal routes is minimal 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study.

The journal of allergy and clinical immunology. In practice, 2015

Research

Is it safe to use inhaled corticosteroids in pregnancy?

Canadian family physician Medecin de famille canadien, 2014

Research

Fluticasone propionate aqueous nasal spray in pregnancy rhinitis.

Clinical otolaryngology and allied sciences, 2001

Research

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018

Guideline

Sécurité du Béclométhasone Aqueux Nasal pendant la Grossesse

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.